Next Article in Journal
Hematological and Biochemical Reference Ranges for the Population with Sickle Cell Disease at Steady State in Tanzania
Next Article in Special Issue
What Is Genomic High-Risk Myeloma?
Previous Article in Journal
Mechanisms of Organ Damage and Novel Treatment Targets in AL Amyloidosis
Previous Article in Special Issue
Will Mass Spectrometry Replace Current Techniques for Both Routine Monitoring and MRD Detection in Multiple Myeloma?
 
 
Review

Article Versions Notes

Hemato 2022, 3(1), 63-81; https://doi.org/10.3390/hemato3010006
Action Date Notes Link
article xml file uploaded 13 January 2022 17:10 CET Original file -
article xml uploaded. 13 January 2022 17:10 CET Update https://www.mdpi.com/2673-6357/3/1/6/xml
article pdf uploaded. 13 January 2022 17:10 CET Version of Record https://www.mdpi.com/2673-6357/3/1/6/pdf
article html file updated 13 January 2022 17:12 CET Original file -
article html file updated 17 January 2022 06:33 CET Update -
article html file updated 17 January 2022 06:33 CET Update -
article html file updated 31 July 2022 03:43 CEST Update https://www.mdpi.com/2673-6357/3/1/6/html
Back to TopTop